Genome Editing and Cellular Therapies Show Promise for Treating Blood Disorders, Cancers |
| December 06, 2020 | December 2020 Bond Updates |
|
WASHINGTON, Dec. 5, 2020 /PRNewswire/ -- Three studies being presented during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition report promising results in the use of cutting-edge genome editing and cellular therapies for hard-to-treat blood disorders and cancers.... |
| View more at: https://www.prnewswire.com:443/news-releases/genome-editing-and-cellular-therapies-show-promise-for-treating-blood-disorders-cancers-301186839.html |
| Related News |
|